Funded Startups in Morrisville
Across the 19 Morrisville-based entries shown (oldest 2021-05-14 to most recent 2025-03-25), the largest disclosed round is Metabolon’s $60M on 2024-05-16.
Across the 19 Morrisville-based entries shown (oldest 2021-05-14 to most recent 2025-03-25), the largest disclosed round is Metabolon’s $60M on 2024-05-16. The only other disclosed amounts in the same high range are Humacyte’s $50M (2025-03-25) and Arrivo BioVentures’ $45M (2023-11-29), while most disclosed rounds cluster far lower (e.g., Locus Biosciences $24M on 2024-01-23; Liquidia Technologies $25M on 2023-12-12).
The table is also concentrated by sector and timing: 11 of 19 entries are categorized in Biotechnology (including Metabolon, Humacyte, Locus Biosciences, Liquidia Technologies, Novan, and Arrivo BioVentures LLC), and 12 of 19 entries carry a “Series Unknown” classification (with Silversky marked “undisclosed” at its 2024-04-18 entry). Date-wise, there is a dense 2023–2024 window for larger disclosed rounds (for example, ETON Solutions $38M on 2022-07-12 sits earlier, while Metabolon $60M, Silversky (undisclosed), Locus Biosciences $24M, and Humacyte $50M fall across 2024–2025).
Most recent rounds
19 shownRelated listings
Frequently asked
What stands out as the biggest disclosed round in Morrisville, and how far above the rest is it?
Metabolon’s $60M round on 2024-05-16 is the largest disclosed amount in the 19-row list. Humacyte follows with $50M on 2025-03-25, and Arrivo BioVentures LLC posts $45M on 2023-11-29, while most other disclosed rounds are well below that top tier (for example, Locus Biosciences $24M on 2024-01-23 and Liquidia Technologies $25M on 2023-12-12).
Which sector dominates the list, and how much of the 19 entries does it represent?
Biotechnology is the dominant category with 11 of 19 entries, including Humacyte ($50M, 2025-03-25), Metabolon ($60M, 2024-05-16), Locus Biosciences ($24M, 2024-01-23), Liquidia Technologies ($25M, 2023-12-12), Novan ($15M, 2023-07-17), and Arrivo BioVentures LLC ($45M, 2023-11-29).
Is there a concentration of rounds in a specific time window within the shown dates?
Large, disclosed rounds cluster across 2023–2024 into early 2025: Metabolon $60M (2024-05-16), Silversky (undisclosed) (2024-04-18), Locus Biosciences $24M (2024-01-23), Liquidia Technologies $25M (2023-12-12), Arrivo BioVentures LLC $45M (2023-11-29), and Humacyte $50M (2025-03-25). Earlier entries include ETON Solutions at $38M on 2022-07-12 and TARGAN at $35M on 2022-05-25.
How should a buyer interpret stage signals here, given the prevalence of unspecified stages?
Stage disclosure is limited: 12 of 19 entries are labeled “Series Unknown.” Two additional stage-related edge cases are also present: Silversky is marked “undisclosed” at $undisclosed on 2024-04-18, and Gilero (2021-05-14) has a blank Series classification while still listing $5M.
Are there outliers by size or by amount disclosure that merit follow-up?
Yes. Incredible Eats lists just $20K (2023-05-04), which is far below the next-low disclosed amounts such as JupiterOne at $250K (2022-06-29) and Soil Health Institute at $300K (2023-02-09). At the other end, Silversky is an outlier due to missing disclosed economics: its entry on 2024-04-18 is marked “undisclosed” rather than a dollar amount.
Which stage labels appear in multiple rows, and are any amount ranges associated with them?
Among non-“Series Unknown” labels, Seed appears in two entries (PlayMetrics $5M on 2022-08-29; Tactyc $2M on 2022-11-17) and “Series C” appears in two entries (ETON Solutions $38M on 2022-07-12; TARGAN $35M on 2022-05-25). Venture-labeled entries also recur twice (Gusto Global in 2022-09-21 with $2M and SmartSky Networks in 2022-06-13 with $27M), indicating multiple growth-finance points with differing disclosed ranges.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.